Dave Muoio

June 18, 2018
To all of the people who work with machine learning and neural networks healthcare technologies, but can’t describe exactly how the gears are turning — don’t worry, you’re not alone. In a sold-out discussion hosted at Optum’s Boston office and organized by the Design Museum Foundation, Sanji Fernando, vice president and head of OptumLabs’ Center for Applied Data Science, explained how the ongoing...
June 18, 2018
Pasadena, California-based Embodied announced today it has raised $22 million in Series A funding to support its AI and robotics platforms for improved care and wellness. The investment is led by Calibrate Ventures and Jazz Venture Partners, and had participation from previous backers including Osage University Partners, Intel Capital, Grishin Robotics, and others. “We are developing a software...
DreaMed Diabetes tool gets FDA approval
June 18, 2018
The FDA has granted Isreal-based DreaMed Diabetes a de novo request for its artificial intelligence-powered software for providers managing patients with Type 1 diabetes. “This is an innovation that can improve people’s lives and the FDA decision confirms what we believe is an important step in making a more meaningful connection between the healthcare provider and their type 1 diabetes patients...
June 14, 2018
Biometric sensor technology company Valencell announced this week that it has raised $10.5 million in Series E, bringing the company’s total funding to $35 million. The new backing primarily comes as the result of a strategic investment by hearing instrument and specialty earphone company Sonion a/s, with additional participation from prior investors including TDF Ventures, GII LLC, and WSJ...

Credit: FDA.gov

June 14, 2018
DyAnsys, a medical device company specializing in the autonomic nervous system, announced this week that it has received FDA approval for a wearable auricular neurostimulation device designed to treat symptoms of opioid withdrawal. The device, called Drug Relief, is now available to providers in the US, and is distributed in the EU by the DyAnsys’ European branch. "This device offers hope to...
June 14, 2018
The past month has seen a succession of publications offering support for Click Therapeutics’ digital offering for patients with major depressive disorder (MDD). The studies, published in npj Digital Medicine, the Journal of Affective Disorders, and presented at the Society of Biological Psychiatry Annual Scientific Convention in New York, showed the therapeutic to reduce symptoms, pair well with...
June 13, 2018
SleepScore Labs — a joint venture between ResMed, Dr. Oz Media, and Pegasus Capital Advisors best known for its contactless, bedside sleep quality measurement device — has launched a new offering that relies only on the user’s smartphone. The SleepScore App uses the phone’s speakers as a SONAR system by projecting inaudible soundwaves around the bedroom. Once these reflect off of the user’s...
June 13, 2018
Stockholm, Sweden-based telemedicine app company Kry announced this week that it has raised $66 million (53 million euros) in Series B funding. The round was led by Index Ventures, and also included the company’s existing investors Accel, Creandum, and Project A. According to a statement, the company will use the new funding to grow its staff, with the eventual goals of deepening market...
June 12, 2018
When healthcare communications firm Spok first began investigating the prevalence of mobile strategies in 2012, only a third of survey respondents reported that their organization had a formalized strategy in place. While this number has generally increased over time, the company’s most recent annual survey of US healthcare professionals found, for the first time, a decrease in the year-to-year...
June 12, 2018
Switzerland-based MindMaze announced today that it has received FDA clearance for the MindMotion Go, a gamified neurorehabilitation therapy platform for medium and light severity impairments able to be deployed in the patient’s home. Using motion capture technology based on the Microsoft Kinect, the Go engages patients with a range of activities set in displayed 3D environments that promote motor...